LUNCH AND LEARN: FUEL FOR THE CLIMB

Join us in welcoming Daybreak Labs' new R&D Advisor and biotech expert, Dr. Klint Rose, for an essential conversation about navigating your startup's path to success.

Every biotech founder faces a pivotal question: which funding path will lead to success? The answer isn't one-size-fits-all. In this insightful session, Dr. Rose will reveal that multiple funding routes can lead to successful outcomes for your company.

Klint will challenge you to evolve from a "technical founder" focused on the science to a "company builder" who understands the full landscape of business development. You'll explore why this mindset shift is crucial for navigating the complex decisions ahead and determining the right path for your unique situation.

You'll learn the critical questions that successful founders ask themselves—and their advisors, board members, and mentors—when evaluating funding options. Whether you're considering venture capital, grants, strategic partnerships, or alternative funding models, you'll leave with a clearer understanding of how to assess which path aligns with your company's goals and your personal vision for success.

Perfect for early-stage biotech founders, technical leaders transitioning to CEO roles, and anyone navigating the intersection of scientific innovation and business strategy.

Speaker Bio:

Dr. Klint Rose is an accomplished R&D executive and biotechnology innovator with over two decades of experience driving breakthrough technologies from concept to commercialization — turning cutting-edge research into impactful products and companies. Klint began his career at Lawrence Livermore National Laboratory, where he directed multimillion-dollar projects spanning biotech, energy, and advanced manufacturing. His subsequent work included positions at Bio-Rad Laboratories and QuantaLife, helping bring Droplet Digital PCR technology to market — a transformative innovation in quantitative biology. His love of applying microfluidic technologies and instrumentation to solve biological problems resulted in him co-founding and leading Purigen Biosystems, which pioneered the ITP process for isolating and purifying DNA and RNA from biological samples. This company was acquired by Bionano Genomics Inc. (NASDAQ: BNGO), where he then served as Head of Research and Development.

Dr. Rose holds a Ph.D. in Mechanical Engineering from Stanford University and B.S./M.S. degrees in Mechanical Engineering from MIT.